{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-215218","form_type":"8-K","ticker":"PSTV","cik":"0001095981","company_name":"PLUS THERAPEUTICS, INC.","filed_at":"2024-09-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.159026+00:00","generated_at":"2026-05-31T06:01:35.484897+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Plus Therapeutics receives Nasdaq delisting notice; plans appeal to stay listing","bullets":["Nasdaq notified on Sept 5, 2024 that company failed to regain compliance with minimum $2.5M stockholders' equity rule.","Company intends to timely appeal, which automatically stays suspension/delisting pending hearing.","Prior disclosure: stockholders' equity was ($1.348M) as of Dec 31, 2023.","No assurance that Nasdaq Hearings Panel will grant continued listing or extension."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-215218","json":"https://secwatch.observer/filing/0001193125-24-215218.json","markdown":"https://secwatch.observer/filing/0001193125-24-215218.md","text":"https://secwatch.observer/filing/0001193125-24-215218.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1095981/000119312524215218/0001193125-24-215218-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1095981/000119312524215218/d821033d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T06:01:35.484897+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}